Literature DB >> 12920602

Benefits and limitations of Kaplan-Meier calculations of survival chance in cancer surgery.

Elfriede Bollschweiler1.   

Abstract

BACKGROUND AND AIM: Especially in malign diseases, the therapeutic decision depends on the prognosis for the individual patient. A prognosis is a prediction of the future course of disease following its onset. Graphical representation of such statistical results-such as the well-known Kaplan-Meier curve-is often used to assist readers of a paper in the interpretation. However, mistakes and distortions frequently arise in the display and interpretation of survival plots. This review aims to highlight such pitfalls and provide recommendations for future practice.
METHODS: Special topics are discussed: the criteria for the presentation of the survival curve, the problem of missing values, estimation of the prognosis in the presence of competing risks, comparison of treatment effects and analysis of survival by tumour-response category.

Entities:  

Mesh:

Year:  2003        PMID: 12920602     DOI: 10.1007/s00423-003-0410-6

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  17 in total

1.  Parametric modeling for survival with competing risks and masked failure causes.

Authors:  Betty J Flehinger; Benjamin Reiser; Emmanuel Yashchin
Journal:  Lifetime Data Anal       Date:  2002-06       Impact factor: 1.588

2.  [Prognostic relevance of biological and molecular markers in oncology. Criteria for planning and interpreting studies].

Authors:  E Bollschweiler; P M Schneider; S P Mönig; A Altendorf-Hofmann; U Mansmann; W Lehmacher; P M Schlag; S Merkel; W Hohenberger; J R Izbicki; P Hermanek; A H Hölscher
Journal:  Chirurg       Date:  2003-02       Impact factor: 0.955

3.  Survival curve estimation with partial non-random exposure information.

Authors:  Ron Brookmeyer; Frank C Curriero
Journal:  Stat Med       Date:  2002-09-30       Impact factor: 2.373

4.  Missing cause of death information in the analysis of survival data.

Authors:  J Andersen; E Goetghebeur; L Ryan
Journal:  Stat Med       Date:  1996-10-30       Impact factor: 2.373

5.  Analysis and interpretation of the comparison of survival by treatment outcome variables in cancer clinical trials.

Authors:  J R Anderson; K C Cain; R D Gelber; R S Gelman
Journal:  Cancer Treat Rep       Date:  1985-10

6.  Methodologic guidelines for reports of clinical trials.

Authors:  R Simon; R E Wittes
Journal:  Cancer Treat Rep       Date:  1985-01

7.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

8.  Quantification of the completeness of follow-up.

Authors:  Taane G Clark; Douglas G Altman; Bianca L De Stavola
Journal:  Lancet       Date:  2002-04-13       Impact factor: 79.321

9.  A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias.

Authors:  R Simon; R W Makuch
Journal:  Stat Med       Date:  1984 Jan-Mar       Impact factor: 2.373

10.  Improved methodology for analyzing local and distant recurrence.

Authors:  R Gelman; R Gelber; I C Henderson; C N Coleman; J R Harris
Journal:  J Clin Oncol       Date:  1990-03       Impact factor: 44.544

View more
  15 in total

1.  Neoadjuvant radiochemotherapy in adenocarcinoma of the esophagus: ERCC1 gene polymorphisms for prediction of response and prognosis.

Authors:  Ralf Metzger; Ute Warnecke-Eberz; Hakan Alakus; Fabian Kütting; Jan Brabender; Daniel Vallböhmer; Peter P Grimminger; Stefan P Mönig; Uta Drebber; Arnulf H Hölscher; Elfriede Bollschweiler
Journal:  J Gastrointest Surg       Date:  2011-09-29       Impact factor: 3.452

2.  ERCC1 and XRCC1 gene polymorphisms predict response to neoadjuvant radiochemotherapy in esophageal cancer.

Authors:  Ute Warnecke-Eberz; Daniel Vallböhmer; Hakan Alakus; Fabian Kütting; Georg Lurje; Elfriede Bollschweiler; Anke Wienand-Dorweiler; Uta Drebber; Arnulf H Hölscher; Ralf Metzger
Journal:  J Gastrointest Surg       Date:  2009-05-07       Impact factor: 3.452

3.  Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma.

Authors:  Fabio Bagante; Gaya Spolverato; Matthew Weiss; Sorin Alexandrescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Oliver Soubrane; Guillaume Martel; B Groot Koerkamp; Alfredo Guglielmi; Endo Itaru; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-08-24       Impact factor: 3.452

Review 4.  Mortality in patients with multiple sclerosis.

Authors:  Antonio Scalfari; Volker Knappertz; Gary Cutter; Douglas S Goodin; Raymond Ashton; George C Ebers
Journal:  Neurology       Date:  2013-07-09       Impact factor: 9.910

5.  Comparison of minimal invasive versus open radical antegrade modular pancreatosplenectomy (RAMPS) for pancreatic ductal adenocarcinoma: a single center retrospective study.

Authors:  Hanyu Zhang; Yatong Li; Quan Liao; Cheng Xing; Cheng Ding; Taiping Zhang; Junchao Guo; Xianlin Han; Qiang Xu; Wenming Wu; Yupei Zhao; Menghua Dai
Journal:  Surg Endosc       Date:  2020-10-08       Impact factor: 4.584

6.  SOX2 and nestin expression in human melanoma: an immunohistochemical and experimental study.

Authors:  Alvaro C Laga; Qian Zhan; Carsten Weishaupt; Jie Ma; Markus H Frank; George F Murphy
Journal:  Exp Dermatol       Date:  2011-04       Impact factor: 3.960

7.  [Submucosal infiltration and local recurrence in pT1 low-risk rectal cancer treated by transanal endoscopic microsurgery].

Authors:  H Schäfer; S E Baldus; F Gasper; A H Hölscher
Journal:  Chirurg       Date:  2005-04       Impact factor: 0.955

8.  Neoadjuvant chemoradiotherapy for esophageal cancer: impact on extracapsular lymph node involvement.

Authors:  Ralf Metzger; Elfriede Bollschweiler; Uta Drebber; Stefan P Mönig; Wolfgang Schröder; Hakan Alakus; Martin Kocher; Stephan E Baldus; Arnulf H Hölscher
Journal:  World J Gastroenterol       Date:  2010-04-28       Impact factor: 5.742

9.  Mean and maximum standardized uptake values in [18F]FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapy.

Authors:  Matthias Schmidt; Elfriede Bollschweiler; Markus Dietlein; Stefan P Mönig; Carsten Kobe; Daniel Vallböhmer; Daniel Vallboehmer; Wolfgang Eschner; Arnulf Hölscher; Harald Schicha
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-12-19       Impact factor: 9.236

Review 10.  Detection and management of extrahepatic colorectal cancer in patients with resectable liver metastases.

Authors:  Yolanda Y L Yang; James W Fleshman; Steven M Strasberg
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.